Citation: A. Rickinson, THE ROLE OF HERPESVIRUSES IN IMMUNE DEFICIENCY-ASSOCIATED LYMPHOMAS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 17-17
Authors:
BLAKE N
LEE S
REDCHENKO I
THOMAS W
STEVEN N
LEESE A
STEIGERWALDMULLEN P
KURILLA MG
FRAPPIER L
RICKINSON A
Citation: N. Blake et al., HUMAN CD8(-CELL RESPONSES TO EBV EBNA1 - HLA CLASS-I PRESENTATION OF THE (GLY-ALA)-CONTAINING PROTEIN REQUIRES EXOGENOUS PROCESSING() T), Immunity, 7(6), 1997, pp. 791-802
Citation: F. Nitsche et al., EPSTEIN-BARR-VIRUS LEADER PROTEIN ENHANCES EBNA-2-MEDIATED TRANSACTIVATION OF LATENT MEMBRANE-PROTEIN-1 EXPRESSION - A ROLE FOR THE W1W2 REPEAT DOMAIN, Journal of virology, 71(9), 1997, pp. 6619-6628
Authors:
NONKWELO C
SKINNER J
BELL A
RICKINSON A
SAMPLE J
Citation: C. Nonkwelo et al., TRANSCRIPTION START SITES DOWNSTREAM OF THE EPSTEIN-BARR-VIRUS (EBV) FP PROMOTER IN EARLY-PASSAGE BURKITT-LYMPHOMA CELLS DEFINE A 4TH-PROMOTER FOR EXPRESSION OF THE EBV EBNA-1 PROTEIN, Journal of virology, 70(1), 1996, pp. 623-627
Authors:
TYNELL E
AURELIUS E
BRANDELL A
JULANDER I
WOOD M
YAO QY
RICKINSON A
AKERLUND B
ANDERSSON J
Citation: E. Tynell et al., ACYCLOVIR AND PREDNISOLONE TREATMENT OF ACUTE INFECTIOUS-MONONUCLEOSIS - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, The Journal of infectious diseases, 174(2), 1996, pp. 324-331
Authors:
HILL A
WORTH A
ELLIOTT T
ROWLANDJONES S
BROOKS J
RICKINSON A
MCMICHAEL A
Citation: A. Hill et al., CHARACTERIZATION OF 2 EPSTEIN-BARR-VIRUS EPITOPES RESTRICTED BY HLA-B7, European Journal of Immunology, 25(1), 1995, pp. 18-24
Authors:
TAKAYAMA S
CAZALSHATEM DL
KITADA S
TANAKA S
MIYASHITA T
HOVEY LR
HUEN D
RICKINSON A
VEERAPANDIAN P
KRAJEWSKI S
SAITO K
REED JC
Citation: S. Takayama et al., EVOLUTIONARY CONSERVATION OF FUNCTION AMONG MAMMALIAN, AVIAN, AND VIRAL HOMOLOGS OF THE BCL-2 ONCOPROTEIN, DNA and cell biology, 13(7), 1994, pp. 679-692
Authors:
HENDERSON S
HUEN D
ROWE M
DAWSON C
JOHNSON G
RICKINSON A
Citation: S. Henderson et al., EPSTEIN-BARR VIRUS-CODED BHRF1 PROTEIN, A VIRAL HOMOLOG OF BCL-2, PROTECTS HUMAN B-CELLS FROM PROGRAMMED CELL-DEATH, Proceedings of the National Academy of Sciences of the United Statesof America, 90(18), 1993, pp. 8479-8483